[1]National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann H P, Wheeler A P, et al. Comparison of two fluid-management strategies in acute lung injury[J]. N Engl J Med, 2006, 354(24):2564-2575.
[2]Silversides J A, Major E, Ferguson A J, et al Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis[J]. Intensive Care Med, 2017, 43(2):155-170.
[3]Murphy C V, Schramm G E, Doherty J A, et al. The importance of fluid management in acute lung injury secondary to septic shock[J]. Chest, 2009, 136(1):102-109.
(资料图片仅供参考)
[4]Chang D W, Huynh R, Sandoval E, et al. Volume of fluids administered during resuscitation for severe sepsis and septic shock and the development of the acute respiratory distress syndrome[J]. J Crit Care, 2014, 29(6):1011-1015.
[5]Marik P E, Linde-Zwirble W T, Bittner E A, et al. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database[J]. Intensive Care Med, 2017, 43(5):625-632.
[6]Vignon P, Evrard B, Asfar P, et al. Fluid administration and monitoring in ARDS: which management?[J]. Intensive Care Med, 2020, ;46(12):2252-2264.
[7]Mitchell J P, Schuller D, Calandrino F S, et al. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization[J]. Am Rev Respir Dis, 1992, 145:990-998.
[8]Stewart R M, Park P K, Hunt J P, et al. Less is more: improved outcomes in surgical patients with conservative fluid administration and central venous catheter monitoring[J]. J Am Coll Surg, 2009, 208:725-737.
[9]Reilly J P, Bellamy S, Shashaty M G, et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma[J]. Ann Am Thorac Soc, 2014, 11(5):728-736.
[10]Bos L D, Schouten L R, van Vught L A, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis[J]. Thorax, 2017, 72(10):876-883.
[11]Calfee C S, Delucchi K, Parsons P E, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials[J]. Lancet Respir Med, 2014, 2(8):611-620.
[12]Famous K R, Delucchi K, Ware LB, et al. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy[J]. Am J Respir Crit Care Med, 2017, 195(3):331-338.
[13]Semler M W, Marney A M, Rice T W, et al. B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS[J]. Chest, 2016, 150(1):102-111.
[14]Jolley S E, Hough C L, Clermont G, et al. Relationship between Race and the Effect of Fluids on Long-term Mortality after Acute Respiratory Distress Syndrome. Secondary Analysis of the National Heart, Lung, and Blood Institute Fluid and Catheter Treatment Trial[J]. Ann Am Thorac Soc, 2017, 14(9):1443-1449.
[15]Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock[J]. N Engl J Med, 2014, 370(15):1412-1421.
[16]Chian C F, Tsao C M, Chen S J, et al. Hyperoncotic albumin attenuates lung and intestine injuries caused by peritonitis-induced sepsis in rats[J]. J Surg Res, 2013, 182(1):134-141.
[17]Powers K A, Kapus A, Khadaroo R G, et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation[J]. Crit Care Med, 2003, 31(9):2355-2363.
[18]Martin G S, Mangialardi R J, Wheeler A P, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury[J]. Crit Care Med, 2002, 30(10):2175-2182.
关键词：
